Prevention · Screening · Early detection
Family History, Genetics and Hereditary Cancer
A family history can identify people who need a different prevention plan. Genetic counselling helps decide what to test and how to interpret the result.
Chapter 14 of 16
Choose a chapter
Key facts
- Inherited susceptibility can come from either parent.
- A tumour gene result is not automatically an inherited result.
- A variant of uncertain significance usually should not drive irreversible surgery.
From information to action
| Action | How to use it |
|---|---|
| Collect information from both sides of the family with consent. | Discuss feasibility and any relevant medical conditions with your healthcare team. |
| Ask for counselling when red flags or a known familial variant are present. | Discuss feasibility and any relevant medical conditions with your healthcare team. |
| Keep the original laboratory classification and date. | Discuss feasibility and any relevant medical conditions with your healthcare team. |
| Do not change screening or choose surgery solely from a VUS. | Discuss feasibility and any relevant medical conditions with your healthcare team. |
Choose the right next step
- New or concerning symptoms? Arrange diagnostic assessment. Severe bleeding, breathlessness or new neurological weakness needs urgent care.
- No symptoms, but previous cancer, precancer or increased inherited risk? Ask for an individual surveillance plan; average-risk intervals may not apply.
- No such history? Use this chapter to discuss prevention and, where appropriate, age- and test-specific screening. Lifestyle exposures alone do not establish eligibility for every test.
- After testing: Collect the result, complete any referral, and record the next review date. A normal screen does not explain a later symptom.
Red flags in a family
Cancer at an unusually young age, several related cancers on one side of a family, multiple primary cancers in one person, bilateral disease and rare patterns such as male breast cancer can warrant assessment. Ovarian cancer, pancreatic cancer or aggressive prostate cancer in a family can also be relevant. Small families and missing information may conceal a pattern; no checklist excludes hereditary risk.
Examples of hereditary syndromes
BRCA1, BRCA2 and PALB2 can be associated with breast and other cancer risks, with risks varying by gene. Lynch syndrome involves mismatch-repair genes such as MLH1, MSH2, MSH6 and PMS2, or certain EPCAM alterations, and can affect colorectal, endometrial and other organs. FAP, usually associated with APC, causes numerous bowel polyps. Hereditary pancreatic and prostate susceptibility may overlap with breast/ovarian syndromes.
Germline versus somatic testing
Germline testing usually uses blood or saliva to look for inherited variants. Somatic testing studies tumour changes, often to guide treatment. A tumour finding can suggest germline testing but does not establish it; confirmation and counselling may be needed. Testing an affected relative first can make results more informative. A negative result in an unaffected person may be uninformative if the familial cause is unknown.
Panels and uncertain findings
Multigene panels can identify more than one possible syndrome but also increase uncertain findings. Pathogenic or likely pathogenic variants may change management; a variant of uncertain significance means evidence is insufficient. Do not treat a VUS as a positive result or ordinarily use it to justify irreversible risk-reducing intervention. Follow clinical and family history while the laboratory or genetics service considers reclassification.
Cascade testing and prevention choices
When a familial pathogenic variant is known, targeted testing can be offered to appropriate relatives after counselling. Surveillance may include earlier MRI or colonoscopy, depending on the gene. Medicines or surgery can be considered in selected syndromes after discussion of benefits, residual risk, fertility, menopause and long-term effects. Testing children depends on whether results would change care during childhood; adult-onset risk does not automatically justify childhood testing.
A family-history checklist and privacy
Record the relative, maternal or paternal side, primary cancer type, age at diagnosis, multiple cancers and any genetic report. Avoid guessing the primary organ from where a cancer spread. Bring actual reports when relatives consent. Discuss emotional effects, who will receive results, costs and implications for family members. In India, ask for a genetics service experienced in cancer rather than choosing a commercial panel by the number of genes.
Practical steps
- Collect information from both sides of the family with consent.
- Ask for counselling when red flags or a known familial variant are present.
- Keep the original laboratory classification and date.
- Do not change screening or choose surgery solely from a VUS.
Myth and fact
A negative panel removes all inherited risk.
False. Some tests are uninformative, genes may be unknown, and family history may still justify surveillance.
Frequently asked questions
Can inherited risk come through my father?
Yes. Either parental side can transmit relevant variants.
Does a positive result mean cancer is inevitable?
No. Risk and recommended actions depend on the gene, variant and personal situation.
Continue learning
Sources and guideline context
- NCI — Genetic testing for inherited cancer risk
Living resource
- NCI — BRCA gene changes
Living resource